Oxford BioTherapeutics Ltd
1 clinical trials · Sponsor
◉ Watch Oxford BioTherapeutics Ltd
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid Tumors (NCT04064359) | Oxford BioTherapeutics Ltd | 2019-07-25 |
Track Oxford BioTherapeutics Ltd automatically
Every clearance here is in the API, with alerts when new ones post.